Issue 2, 2016

Correction: Inclusion of new 5-fluorouracil amphiphilic derivatives in liposome formulation for cancer treatment

Abstract

Correction for ‘Inclusion of new 5-fluorouracil amphiphilic derivatives in liposome formulation for cancer treatment’ by M. Petaccia et al., Med. Chem. Commun., 2015, 6, 1639–1642.

Associated articles

Article information

Article type
Correction
Submitted
02 Dec 2015
Accepted
02 Dec 2015
First published
10 Dec 2015
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2016,7, 378-378

Correction: Inclusion of new 5-fluorouracil amphiphilic derivatives in liposome formulation for cancer treatment

M. Petaccia, M. Condello, L. Giansanti, A. La Bella, F. Leonelli, S. Meschini, D. Gradella Villalva, E. Pellegrini, F. Ceccacci, L. Galantini and G. Mancini, Med. Chem. Commun., 2016, 7, 378 DOI: 10.1039/C5MD90061A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements